Johnson & Johnson (JNJ) Financials

JNJ Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 178.3 billion 108.1 billion
June 30, 2024 181.1 billion 109.6 billion
March 31, 2024 172.0 billion 101.9 billion
Dec. 31, 2023 167.6 billion 98.8 billion

JNJ Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 5.7 billion 295.0 million
June 30, 2024 4.7 billion 341.0 million
March 31, 2024 2.9 billion 302.0 million
Dec. 31, 2023 6.3 billion 178.0 million

JNJ Net Income
Graph available only for supporters. Become a supporter to see it.
DateNet Income
Sept. 30, 2024 2.7 billion
June 30, 2024 4.7 billion
March 31, 2024 3.3 billion
Dec. 31, 2023 4.1 billion

JNJ Cash and Debt
Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 20.3 billion 31.3 billion -
June 30, 2024 25.5 billion 31.6 billion -
March 31, 2024 26.2 billion 25.1 billion -
Dec. 31, 2023 22.9 billion 25.9 billion -

JNJ Shares Outstanding
Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
Sept. 30, 2024 2.4 billion
June 30, 2024 2.4 billion
March 31, 2024 2.4 billion
Dec. 31, 2023 2.4 billion

JNJ Expenses
Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 2.3 billion 5.0 billion 5.3 billion -
June 30, 2024 976.0 million 3.4 billion 5.5 billion -
March 31, 2024 807.0 million 3.5 billion 5.1 billion 200.0 million
Dec. 31, 2023 1.6 billion 4.5 billion 5.5 billion 500.0 million

JNJ Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 22.5 billion 7.0 billion
June 30, 2024 22.4 billion 6.9 billion
March 31, 2024 21.4 billion 6.5 billion
Dec. 31, 2023 21.4 billion 6.8 billion

JNJ Revenue by Segment
Graph available only for supporters. Become a supporter to see it.

JNJ

List: Champions

Price: $163.02

52 week price:
140.68
169.99

Dividend Yield: 3.12%

5-year range yield:
2.48%
3.37%

Forward Dividend Yield: 3.04%

Payout Ratio: 75.04%

Payout Ratio Range:
-4326.47%
713.30%

Dividend Per Share: 4.96 USD

Earnings Per Share: 5.79 USD

P/E Ratio: 28.57

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 6.9 million

Ebitda: 2.9 billion

Market Capitalization: 398.3 billion

Average Dividend Frequency: 4

Years Paying Dividends: 25

DGR3: 5.62%

DGR5: 5.75%

DGR10: 6.07%

DGR20: 8.40%

Links: